EMERYVILLE, Calif. (Sept. 13, 2018) – KBS, based in Newport Beach, California, announced today the signing of a lease expansion at the Towers at Emeryville in Emeryville, California. The existing tenant, BeiGene USA, Inc., a wholly-owned subsidiary of BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing molecularly-targeted and immuno-oncology drugs for the treatment of cancer, expanded its lease to 21,221 square feet. The property is part of the KBS Real Estate Investment Trust III portfolio.